Registered Kenya · PPB

FENCUR 250 BOLUS

FEBENDAZOLE BP

V2008/16087/043 250 MG

What it does

Febendazole is a medication used to treat certain types of worm infections.

Commonly used for: worm infections, parasitic infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
V2008/16087/043
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
FEBENDAZOLE BP
Dosage form
250 MG
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Nairobi Enterprises
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
JWW2+25R, Old Mombasa Rd, Nairobi. Shiv business park, Opposite SGR Nairobi terminus-old Mombasa road , Warehouse NO-15, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:16:22 · updated 2026-07-20 08:59:33

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Febendazole is a medication used to treat certain types of worm infections.

What it treats

  • worm infections
  • parasitic infections

How it works

Febendazole works by killing the worms and preventing them from growing and reproducing.

Who it's for

It is suitable for people diagnosed with specific worm infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: febendazole

Febendazole is an anthelmintic agent used primarily in the treatment of parasitic infections caused by nematodes and some cestodes. It is commonly utilized in veterinary medicine but has been studied for its potential use in humans. Febendazole works by inhibiting the polymerization of tubulin, leading to the disruption of microtubule formation, which is critical for various cellular functions in parasites.

Indications

  • Ascariasis
  • Enterobiasis
  • Hookworm infection
  • Strongyloidiasis
  • Trichuriasis
  • Cestode infections

Dosage

Children: Refer to the specific prescribing guidelines and clinical protocols for dosing in children, as it may vary based on age and weight.

Adults: Refer to the specific prescribing guidelines and clinical protocols for dosing, as it may vary based on the type of infection and patient factors.

Mechanism of action

Febendazole exerts its anthelmintic effect by inhibiting the polymerization of tubulin into microtubules, disrupting the cytoskeletal structure necessary for cell division and metabolic activity in helminths. This leads to impaired glucose uptake and eventual death of the parasite.

Pharmacodynamics

The pharmacodynamic effects of febendazole involve its selective action on parasitic worms, resulting in their immobilization and death. The drug has a broad spectrum of activity against various nematodes and some species of cestodes. Its efficacy is enhanced in the presence of food, which may increase the drug’s absorption and bioavailability.

Pharmacokinetics

Febendazole is poorly absorbed from the gastrointestinal tract, which limits its bioavailability. However, it is metabolized in the liver to its active form, fenbendazole sulfoxide, which exhibits greater anthelmintic activity. The elimination half-life varies depending on the species being treated, and the drug is excreted primarily in feces. It has a variable duration of action, often requiring repeated doses for complete eradication of the infection.

Adverse effects

  • Abdominal pain
  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Dizziness

Precautions

  • Use with caution in patients with liver or kidney impairment
  • Avoid use in patients with a known hypersensitivity to benzimidazoles
  • Consider potential for teratogenic effects in pregnancy

Pregnancy

Febendazole is not recommended during pregnancy due to potential risks to the fetus.

Breast-feeding

It is advisable to avoid use during breastfeeding, as safety in lactation has not been established.

Storage

Store at room temperature, protected from light and moisture.

Formulations

  • Tablets
  • Suspensions

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.